Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Dec 6;27(23):14380-5.
doi: 10.1021/la2035278. Epub 2011 Oct 28.

Effects of isoflurane, halothane, and chloroform on the interactions and lateral organization of lipids in the liquid-ordered phase

Affiliations

Effects of isoflurane, halothane, and chloroform on the interactions and lateral organization of lipids in the liquid-ordered phase

Serhan Turkyilmaz et al. Langmuir. .

Abstract

The first quantitative insight has been obtained into the effects that volatile anesthetics have on the interactions and lateral organization of lipids in model membranes that mimic "lipid rafts". Specifically, nearest-neighbor recogntion measurements, in combination with Monte Carlo simulations, have been used to investigate the action of isoflurane, halothane, and chloroform on the compactness and lateral organization of cholesterol-rich bilayers of 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) in the liquid-ordered (l(o)) phase. All three anesthetics induce a similar weakening of sterol-phospholipid association, corresponding to ca. 30 cal/mol of lipid at clinically relevant concentrations. Monte Carlo lattice simulations show that the lateral organization of the l(o) phase, under such conditions, remains virtually unchanged. In sharp contrast to their action on the l(o) phase, these anesthetics have been found to have a similar strengthening effect on sterol-phospholipid association in the liquid-disordered (l(d)) phase. The possibility of discrete complexes being formed between DPPC and these anesthetics and the biological relevance of these findings are discussed.

PubMed Disclaimer

Figures

Figure 1
Figure 1
A stylized illustration showing the exchangeable homodimers, AA and BB and the corresponding heterodimer, AB, plus the equations that describe the dimer equilibrium and the relationship between the equilibrium constant, K, and the corresponding nearest-neighbor interaction free energy, ωAB, between A and B.
Figure 2
Figure 2
Reaction vessel used for carrying out binding measurements.
Figure 3
Figure 3
(A) Plot of XA/P versus isoflurane concentration in buffer at 45°C for cholesterol-rich and cholesterol-poor bilayers. (B) Plot of free energy of interaction between 1 and 2 (i.e., ωAB) as a function of XA/P. Error bars that are not visible lie within the symbols themselves. For each of these measurements, the total concentration of lipid was 4.1 mM.
Figure 4
Figure 4
(A) Plot of XA/P versus halothane concentration in buffer at 45°C for cholesterol-rich and cholesterol-poor bilayers. (B) Plot of free energy of interaction between 1 and 2 (i.e., ωAB) as a function of XA/P. Error bars that are not visible lie within the symbols themselves. For each of these measurements, the total concentration of lipid was 4.1 mM.
Figure 5
Figure 5
(A) Plot of XA/P versus chloroform concentration in buffer at 45°C for cholesterol-rich and cholesterol-poor bilayers. (B) Plot of free energy of interaction between 1 and 2 (i.e., ωAB) as a function of XA/P. Error bars that are not visible lie within the symbols themselves. For each of these measurements, the total concentration of lipid was 4.1 mM.
Figure 6
Figure 6
Plot of Kp versus the concentration of chloroform in buffer, where Kp = [XA/P]liquid-disordered/[XA/P]liquid-ordered.
Figure 7
Figure 7
Composite plot of ωAB as a function of XA/P for isoflurane, halothane and chloroform (data taken from Figures 3,4 and 5).
Chart 1
Chart 1
Chart 2
Chart 2

Similar articles

Cited by

References

    1. Eckenhoff RG. Molecular Interventions. 2001;1:258–268. - PubMed
    1. Franks NP. Br J Pharmacol. 2006;147:S72–S81. - PMC - PubMed
    1. Mohr JT, Gribble GW, Lin S, Eckenhoff RG, Cantor RS. J Med Chem. 2005;48:4172–4176. - PubMed
    1. Janoff AS, Pringle MJ, Miller KW. Biochim Biophys Acta. 1981;649:125–128. - PubMed
    1. Lynch C., III Anesth Analg. 2008;107:864–867. - PubMed

Publication types

MeSH terms